Filter by: patients

Patients using ALS Phase 3 Study Dexpramipexole (KNS-760704)

No patients found using ALS Phase 3 Study Dexpramipexole (KNS-760704) at 2 mg daily

See all patients

2 members have decided to share their profiles only with other members of PatientsLikeMe.